I have been prescribed Xarelto® (rivaroxaban) to either treat DVT or PE, or prevent them from recurring

Patient information booklets

You have been diagnosed with a Deep Vein Thrombosis (DVT) or Pulmonary embolism (PE) and have been prescribed Xarelto to reduce the likelihood of more clots forming.

The following guides are for your information, and they do not replace the patient information leaflet found with your medicine. If you are unsure about why you have been prescribed Xarelto, please speak to your healthcare professional.

Select your language from the drop-down menu:

Select language

To access the latest version of the Xarelto 2.5mg, 10mg and 15/20 mg Summary of Product Characteristics (SmPC) as well as Xarelto Patient Information Leaflet (PIL), please click on the following link eMC Widget

Report Possible Side Effects

This medicine is subject to additional monitoring. This will allow quick identification of new safety information.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store.

You can also report side effects and quality complaints to Bayer Plc. Further information is available on the “contact” tab at www.bayer.co.uk.

By reporting side effects you can help provide more information on the safety of this medicine.